Macroeconomics
11th Edition
ISBN: 9781260506891
Author: Colander
Publisher: MCG
expand_more
expand_more
format_list_bulleted
Question
Chapter 5, Problem 13IP
(a)
To determine
Economy with higher drug prescription.
(b)
To determine
Impact of price control on old drugs but not on new drugs.
(c)
To determine
Benefits for the US doctors for prescribing medicines.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solution
Students have asked these similar questions
In generic drug pricing what is the impact competitors and additional factors have on the results of the generic drug pricing strategies?
Oculus and Maxygen are small drug companies. Oculus has obtained a patent on a new antibiotic that is effective against an emerging
superbug—a
bacteria that is resistant to traditional antibiotics. Unfortunately, the Oculus drug has severe side effects, making the drug unsuitable except for patients who are desperate.
Ownership of this drug is worth
$20
million to Oculus under the current situation. Maxygen has a patent on another drug that is of no therapeutic value in itself so the drug generates no current income for Maxygen. However, when combined in a particular way with the Oculus drug, it dramatically reduces the negative side effects. The value of the two drugs together is estimated at
$55
million. Maxygen is negotiating to sell its patent to Oculus.
Situations of this type are fairly common in the drug business and sales of patent rights are common. However, sometimes negotiations over such sales take a long time and sometimes negotiations are unsuccessful. Why…
Indicate whether each statement is true or false, and justify your answer.In the US, drug companies receive a patent of 100 years for each drug they develop. This allows them a prolonged legal monopoly on the sale of that drug.
Chapter 5 Solutions
Macroeconomics
Ch. 5.1 - Prob. 1QCh. 5.1 - Prob. 2QCh. 5.1 - Prob. 3QCh. 5.1 - Prob. 4QCh. 5.1 - Prob. 5QCh. 5.1 - Prob. 6QCh. 5.1 - Prob. 7QCh. 5.1 - Prob. 8QCh. 5.1 - Prob. 9QCh. 5.1 - Prob. 10Q
Ch. 5.A - Prob. 1QECh. 5.A - Prob. 2QECh. 5.A - Prob. 3QECh. 5.A - Prob. 4QECh. 5.A - Prob. 5QECh. 5.A - Prob. 6QECh. 5.A - Prob. 7QECh. 5.A - Prob. 8QECh. 5.A - Prob. 9QECh. 5 - Prob. 1QECh. 5 - Prob. 2QECh. 5 - Prob. 3QECh. 5 - Prob. 4QECh. 5 - Prob. 5QECh. 5 - Prob. 6QECh. 5 - Prob. 7QECh. 5 - Prob. 8QECh. 5 - Prob. 9QECh. 5 - Prob. 10QECh. 5 - Prob. 11QECh. 5 - Prob. 12QECh. 5 - Prob. 13QECh. 5 - Prob. 14QECh. 5 - Prob. 15QECh. 5 - Prob. 16QECh. 5 - Prob. 17QECh. 5 - Prob. 1QAPCh. 5 - Prob. 2QAPCh. 5 - Prob. 3QAPCh. 5 - Prob. 4QAPCh. 5 - Prob. 5QAPCh. 5 - Prob. 1IPCh. 5 - Prob. 2IPCh. 5 - Prob. 3IPCh. 5 - Prob. 4IPCh. 5 - Prob. 5IPCh. 5 - Prob. 6IPCh. 5 - Prob. 7IPCh. 5 - Prob. 8IPCh. 5 - Prob. 9IPCh. 5 - Prob. 10IPCh. 5 - Prob. 11IPCh. 5 - Prob. 12IPCh. 5 - Prob. 13IPCh. 5 - Prob. 14IP
Knowledge Booster
Similar questions
- 3.4. EZjoint. After spending 10 years and $1.5 billion, you have finally gotten Food and Drug Administration (FDA) approval to sell your new patented wonder drug, which reduces the aches and pains associated with aging joints. You will market this drug under the brand name of EZjoint. Market research indicates that the demand elasticity for EZjoint is 21.25 (at all points on the demand curve). You estimate the marginal cost of manufacturing and selling one more dose of EZjoint is $1. (a) What is the profit-maximizing price per dose of EZjoint? (b) WouldyouexpecttheelasticityofdemandyoufaceforEZjointtoriseorfall when your patent expires? Suppose that, after patent expiry, a generic version of EZjoint was introduced in the market (under the chemical name clorophospartane). Reacting to entry, EZjoint decided to increase price. (c) Can this behavior be consistent with rational profit maximizing? (Cabral, 20170224)arrow_forwardLicensure requirements give physicians a monopoly privilege to practice medicine. As such, they have certain responsibilities and obligations. True Falsearrow_forwardIt is generally agreed that unrestricted price competition among insurers could be detrimental to the public, yet some people argue that antirebating laws represent an unnecessary restriction on price competition among insurance agents and that such laws should be repealed. What is your opinion?arrow_forward
- In the United States, the Food and Drug Administration (FDA) enforces regulations aimed at ensuring that new drugs that are marketed do, in fact, have the functions they are supposed to have. Which of the following arguments provides an appropriate justification for such regulations? These regulations are necessary because: A.verification by each consumer would be extremely inefficient B.verification is an easy task within a market economy C. quantity regulations are so rare within a market economy D. quantity regulations are so efficientarrow_forwardIn the United States, the Food and Drug Administration (FDA) enforces regulations aimed at ensuring that new drugs that are marketed do, in fact, have the functions they are supposed to have. Which of the following arguments provides an appropriate justification for such regulations? These regulations are necessary because: A. verification by each consumer would be extremely inefficient B. verification is an easy task within a market economy C. quantity regulations are so rare within a market economy D. quantity regulations are so efficientarrow_forwardA monopolist hires you to design its pricing policy. After month of doing market research you realize that the own-price elasticity is not the same for different groups of consumers in the market. (a) If group (a) has an own-price elasticity of 2.16 and group (b) 1.26. Assuming that the firm can directly observe an indicator of belonging to groups (a) and (b), what degree of price-discrimination can the monopolist implement? which group will end up paying more? (b) Will producer's surplus increase or decrease with price discrimination? what about consumer surplus? (consider single pricing vs price discrimination) (c) If a you get hold of a magic crystal ball that tells you the exact willingness to pay of each consumer. What type of price discrimination can the monopolist use to maximize profits? is this strategy “efficient” from the point of view of total surplus? are consumers better-off or worse-off? (Hint: A graph can greatly clarify this part.)arrow_forward
- Have Government regulators responded to the apparent change in the effects of concentration on hospital markets and now tend to see competition as beneficial? True or Falsearrow_forwardEvaluate the impact competitors and additional economic factors have on the results of the generic drug pricing strategies. What factors contribute to the advantages and disadvantages of various pricing strategies?arrow_forwardmonopolyStart from a market where a monopoly prevails. Select the option or options below that are correct. Select one or more options: a-The monopolist maximizes profit where MR = MC b-A monopolist always has the opportunity to make a profit c-The individual monopolist has no market power as it meets a completely elastic demand. d-The monopolist will charge a higher price than the marginal cost of the selected quantity. e-The monopolist is free to choose the price charged for a given quantity because consumers have no competitor to go toarrow_forward
- How does monopoly effect the pharmaceutical industry?arrow_forwardWhere will profits be higher: When demand for a patented drug is highly inelastic or when demand for a patented drug is highly elastic? Draw a graphical solution for BOTH to prove your answer (note: you need to have costs, prices etc…included in your answer—since you cannot explain anything in words)arrow_forwardWhy are generic pharmaceuticals significantly cheaper than name brand ones?arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Managerial Economics: A Problem Solving ApproachEconomicsISBN:9781337106665Author:Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike ShorPublisher:Cengage Learning
Microeconomics: Principles & PolicyEconomicsISBN:9781337794992Author:William J. Baumol, Alan S. Blinder, John L. SolowPublisher:Cengage Learning
Principles of Economics 2eEconomicsISBN:9781947172364Author:Steven A. Greenlaw; David ShapiroPublisher:OpenStax
Managerial Economics: A Problem Solving Approach
Economics
ISBN:9781337106665
Author:Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike Shor
Publisher:Cengage Learning
Microeconomics: Principles & Policy
Economics
ISBN:9781337794992
Author:William J. Baumol, Alan S. Blinder, John L. Solow
Publisher:Cengage Learning
Principles of Economics 2e
Economics
ISBN:9781947172364
Author:Steven A. Greenlaw; David Shapiro
Publisher:OpenStax